Tag Archives: Pacific Hep C Network (PHCN)

Pictures of Hep C Advocacy

Hep C AdvocacyMay was a rather busy and colourful month for Pacific Hep C Network’s hep C advocates. It was full of travel, meetings, events, and hep c advocacy.

During all of these outings, PHCN hep C advocates worked to educate the community about hepatitis C. The advocates explained the importance of getting tested for hep C and the treatments that are or will be available to cure hep C. They worked to advocate for those who’s lives have been touched by the disease and to remind everyone that there is hope beyond a diagnosis.

The following are just a few of the pictures that were taken along the way:

First Nations Health Authority event
First Nations Health Authority‘s event Gathering Wisdom VII, May 7-8.

Richmond Centre for Disability's Invisible Illness Awareness Forum
Richmond Centre for Disability‘s Invisible Illness Awareness Forum, May 9th. PHCN’s president, Daryl Luster, presented and participated in a panel discussion. He is fourth from the left.

Pictures of Hep C Advocacy
Daryl Luster, President of the Board of Directors at PHCN, with Action Hepatitis Canada‘s Executive Committee Chair, Patricia Bacon, and Alice Wong, MP for Richmond BC. Daryl was in Ottawa raising awareness and talking to MPs about hep C, screening guidelines, and new advances in therapies that can now cure hep C.

Pictures of Hep C Advocacy
Daryl Luster, President of the Board of Directors at PHCN, with Action Hepatitis Canada‘s Executive Committee Chair, Patricia Bacon, and Carolyn Bennet, MP for St. Paul’s, a constituency located in Toronto, Ontario.

Pictures of Hep C Advocacy
Pacific Blue Cross Workplace Health Symposium, May 14th. Daryl Luster presented with Alnoor Ramji MD FRCP(C), Clinical Associate Professor, Division of Gastroenterology, UBC. They spoke on hep C treatment and management to help employers better understand how to support employees and the benefits new treatment options may offer.

A Hep C Advocate’s February

AdvocacyAs the month changes and we look ahead to warmer seasons full of hope and promise, the Hepatitis C Treatment Information Project wanted to look back and highlight some of the work done last month by one of our hep C advocates.

The following is a collection of meetings and events that Daryl Luster, hep C advocate and president of PHCN, was a part of:

February 5-6 — Toronto, Ontario
Advocacy training and advisory board meetings with representatives from the Canadian Liver Foundation, Hemophilia Society, Canadian Treatment Action Council (CTAC), Action Hepatitis Canada (AHC), HepCBC, as well as other groups from across Canada.

February 10 — Toronto, Ontario
Action Hepatitis Canada (AHC) Steering Committee Meeting
Action Hepatitis Canada is a group that unites organizations and individuals to focus increased attention on the response to hepatitis B and C–diseases that negatively affect the quality of life of up to 600,000 Canadians and their families, friends, caregivers, and communities.

February 11-12 — Toronto, Ontario
A meeting entitled ‘National Deliberative Dialogue on Integrated HCV Programming and Services‘ with CATIE
As part of day two discussions, ‘Addressing Different Realities and Priorities: A Population-Level Discussion’, Daryl presented on the older adult population and participated in a panel discussion, which included presentations from four distinct population groups—indigenous, older adult, immigrant, and people who inject drugs (PWID). A report is to follow.

February 24 — Richmond, British Columbia
A meeting with representatives from UBC’s Faculty of Science regarding PHCN‘s participation in supporting research that impacts the HCV community. Daryl shared his own HCV experience and that of people in the community.

February 24-26 — Richmond, British Columbia
PHCN participated in a conference entitled ‘Frontline Support Workers’ Conference‘ put on by Pacific AIDS Network and CATIE.

February 26-March 1 — Banff, Alberta
Action Hepatitis Canada (AHC)‘s executive meeting and CATIE‘s learning institute meetings
The objective of these meetings was to identify key messages and information from a symposium on HCV, as well as sharing perspectives with participants. Daryl presented on the meeting’s last day.

February 27 — Banff, Alberta
4th Canadian Symposium on HCV
Symposium theme: ‘Strategies to Manage HCV Infection in Canada: Moving Towards a National Action Plan’.
Daryl presented in his roles with Action Hepatitis Canada (AHC) and PHCN. His talk was entitled ‘The role for Patient Advocacy in building a Canadian HCV action plan‘.

In addition, Daryl’s February was filled with additional meetings with researchers and health care providers, including physicians, nurses, and front-line workers, about such topics as harm reduction.

A Hep C Advocate’s 2014

Luster-Daryl-2015As we have just rung in 2015, the Hepatitis C Treatment Information Project wanted to look back and highlight some of the 2014 work of one of our hep C advocates.

The following is a collection of 2014 articles and resources that Daryl Luster, hep C advocate and president of PHCN,  was a part of:

January 13  –  CADTH Letter  (Canadian Agency for Drugs and Technologies in Health)

February 19  –  Daryl Luster and the work of Pacific Hep C Network  (PHCN)

May 30  –  Highly effective new drugs for hepatitis C jostle for market share: No provincial health system covers the medications, but lobbying is already underway to make sure they do  (Vancouver Sun)

July 17  –  Vancouver Resident Raises Awareness for World Hepatitis Day  (Hello Vancity)

July 21  –  Note to Editor: World Hepatitis Day is a time to rethink the future impact of untreated Hepatitis C in Alberta  (iStockAnalyst.com)

July 25  –  Richmondite Spreads Hep C Awareness  (Richmond News)

August 1  –  Hep Stories: Daryl Luster  (hepmag.com)

October 1  –  Hepc.bull Mention and Pictures on Page 5  (hepc.bull)

October 8  –  ‘If you have money, you’ll live. If you don’t, you’ll die’: B.C.’s Hepatitis C sufferers hope for fast drug approval  (The Province)

November 5 – 6  –  Virology Education  (1st International Hepatitis Cure & Eradication Meeting)

November 13  –  Bristol-Myers Squibb Announces High Cure Rates for Genotype 3 Hepatitis C Using Combination of Daclatasvir and Sofosbuvir in ALLY-3 Trial  (Bristol-Myers Squibb)

November 25  –  Richmond Centre for Disability Empower Series  (Richmond Centre for Disability)

December  –  Hepc.bull Mention and Pictures on Page 4  (hepc.bull)

We also wanted to wish you all a happy new year! May the coming year bring new treatments, medical breakthroughs, and hope.